Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2021

View Archived Issues

Liver sequencing gives insight into alcoholic, nonalcoholic disease

Knocking down Snai1 rescues right ventricular failure in rats by blockade of EtM transition

CT-7439: a potential first-in-class oral cyclin K glue degrader

DRD2 rs18000497 polymorphism is a pharmacogenetic marker in schizophrenia patients on haloperidol

New EGFR inhibitors identified at Qilu Pharmaceutical

Akebia Therapeutics presents new prolyl 4-hydroxylase inhibitors

Medshine Discovery discovers HBV cccDNA formation inhibitors

Wigen Biomedicine Technology patents G12C mutant GTPase KRAS inhibitors

New TGF-beta receptor type-1 inhibitors described by Adlai Nortye

CTX-III as a prognostic biomarker of fibrosis progression

RLY-2608, novel mutant and isoform selective inhibitor of PI3Kalpha

IntoCell and Ab Studio establish research collaboration to combine antibody and linker capabilities

BenevolentAI nominates preclinical candidate for novel ulcerative colitis target

LIB-01 shows promise in rats with erectile dysfunction

IL-36gamma-based therapy modulates immune response in pancreatic cancer models

Cell-free miRNAs as biomarkers of COVID-19 pneumonia and ARDS

Antidepressant treatment modulates inflammatory cytokine plasma levels in major depression

Exelixis and Storm Therapeutics collaborate to advance novel drug leads for cancer

NLS reports preclinical data on NLS-4 for long COVID

DeoBioSciences reports preclinical data on DBX-31 in advanced cancers

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026